The Latest in Colorectal Cancer Research
1 Phase III Clinical Trial of FOLFOX with or without Cetuximab in Resected K-ras wild type Stage 3 Colon Cancer: Cooperative Group Trial N0147 (NCCTG*,
Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC) Eric Van Cutsem, MD, PhD University Hospitals Gasthuisberg/Leuven, Leuven,
ASCO 07, June 3rd. ADVANCED PANCREATIC CANCER TREATMENT : NOTHING NEW ?? Christophe Louvet Hôpital St-Antoine Paris, France.
Gropen Pinker
Phase III CORRECT trial of regorafenib in metastatic colorectal cancer ( mCRC )
